First of all in a recent paper on the subject they admitted that there was no significant difference in the prevalence of endoscopic abnormalities among patients taking NSAIDs alone or NSAIDs plus gold if the size of such lesions was not taken into consideration.3 The relation between the claimed gastroprotective properties of gold and Helicobacter pylon infection is also unproved. The role of H pylori in NSAID gastropathy is still debated, but most studies deny that the microorganism can promote or worsen NSAID injury.2 4
The evidence quoted by Taha and Sturrock in favour of an inhibitory effect of gold on H pylori is mostly based on reports which have appeared only as abstracts. Full length papers provide conflicting data.4 5 Taha and Sturrock mention a possible methodological inconsistency,' but negative results arose also in studies where, in addition to H pylori seroprevalence, the urea breath test was used.4 It must also be remembered that the possible bactericidal effect against H pyloni by gold in vitro failed to be confirmed in vivo. 6 Finally, to infer that gold might exert gastroprotective effects similar to those of bismuth, merely because they are classified close to one another in the periodic table of elements, is mere speculation, especially if we consider some experimental reports7 of gold induced gastric mucosal lesions.
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